Luc G.T. Morris

Also affiliated with Kettering University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 59 papers. Top paper: “Improved prediction of immune checkpoint blockade efficacy across multiple cancer types”.

Improved prediction of immune checkpoint blockade efficacy across multiple cancer types

Nature Biotechnology(2021)10.1038/s41587-021-01070-8

N/A

7.3DataRank · unranked

272 citations

Seong‐Keun Yoo, Cristina Valero, Alessandro Pastore, Chirag Krishna, Mark Lee +29 more

Hypoxia-Directed Treatment of Human Papillomavirus–Related Oropharyngeal Carcinoma

Journal of Clinical Oncology(2024)10.1200/jco.23.01308

N/A

1.9DataRank · unranked

94 citations

Eric J. Sherman, Heiko Schöder, Rick Wray, Jay O. Boyle, Bhuvanesh Singh +37 more

Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial

Nature Medicine(2023)10.1038/s41591-023-02518-x

N/A

1.3DataRank · unranked

58 citations

Bharat Burman, Swati Jain, Conall Fitzgerald, Eric J. Sherman, Lara Dunn +24 more

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Nature Medicine(2017)10.1038/nm.4333

N/A

1.2DataRank · unranked

3490 citations

Ryma Benayed, Ronak H Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R. Kim +116 more

High Response Rate and Durability Driven by HLA Genetic Diversity in Patients with Kidney Cancer Treated with Lenvatinib and Pembrolizumab

Molecular Cancer Research(2021)10.1158/1541-7786.mcr-21-0053

N/A

1.2DataRank · unranked

33 citations

Renzo G. DiNatale, Diego Chowell, Chirag Krishna, Vladimir Makarov, Cristina Valero +21 more

Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

Cell(2022)10.1016/j.cell.2022.01.003

N/A

0.973DataRank · unranked

654 citations

Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar +70 more

Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors

Nature Communications(2021)10.1038/s41467-021-20935-9

N/A

0.920DataRank · unranked

459 citations

Mark Lee, Douglas R. Hoen, Kate Weiss, Daniel W. Kelly, Prasad S. Adusumilli +24 more

The association between tumor mutational burden and prognosis is dependent on treatment context

Nature Genetics(2021)10.1038/s41588-020-00752-4

N/A

0.836DataRank · unranked

263 citations

Mark Lee, Douglas R. Hoen, Jingming Wang, Zaineb Nadeem, Neal Patel +22 more

Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa184

N/A

0.762DataRank · unranked

160 citations

Eric J. Sherman, Xin Pei, Heiko Schöder, Milan Grkovski, Ramesh Paudyal +38 more

LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features

Nature Cancer(2024)10.1038/s43018-024-00772-7

N/A

0.712DataRank · unranked

114 citations

Yingying Cao, Hannah J. Sfreddo, Saugato Rahman Dhruba, Se‐Hoon Lee, Cristina Valero +5 more

Disparities and guideline adherence for HPV testing among patients with oropharyngeal squamous cell carcinoma, NCDB, and SEER

Head & Neck(2021)10.1002/hed.26679

N/A

0.345DataRank · unranked

9 citations

Shivangi Lohia, Valentina I. Petkov, Timothy Blackwell, Samuel Swisher‐McClure, Aviram Mizrachi +5 more

Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic Carcinoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1064

N/A

0.344DataRank · unranked

7 citations

Joris L. Vos, Nora Katabi, Fengshen Kuo, Zaineb Nadeem, Maximilian Linxweiler +8 more

Genomic and Transcriptomic Correlates of Thyroid Carcinoma Evolution after BRAF Inhibitor Therapy

Molecular Cancer Research(2021)10.1158/1541-7786.mcr-21-0442

N/A

0DataRank · unranked

20 citations

Brian R. Untch, Bin Xu, Ronald Ghossein, Catherine Han, Fengshen Kuo +12 more

3p Arm Loss and Survival in Head and Neck Cancer: An Analysis of TCGA Dataset

Cancers(2021)10.3390/cancers13215313

N/A

0DataRank · unranked

11 citations

Mushfiq Hassan Shaikh, Mark Lee, Peter YF. Zeng, Alana Sorgini, Temitope Akintola +17 more

The role of immune surveillance in malignant transformation of benign salivary gland tumors

Oncotarget(2021)10.18632/oncotarget.27900

N/A

0DataRank · unranked

3 citations

Jingming Wang, Luc G.T. Morris, Maximilian Linxweiler

Immune determinants of the association between tumor mutational burden and immunotherapy response across cancer types

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.25.445197

N/A

0DataRank · unranked

4 citations

Sanju Sinha, Cristina Valero, Alejandro A. Schäffer, Kenneth Aldape, Kevin Litchfield +4 more

MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.22.457244

N/A

0DataRank · unranked

2 citations

Jonathan Zorea, Sankar Jagadeeshan, Avital Beeri Shnerb, Jebrane Bouaoud, Lucas Michon +24 more

Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity

Nature Genetics(2022)10.1038/s41588-022-01108-w

N/A

0DataRank · unranked

79 citations

Nadeem Riaz, Robert Samstein, Mark Lee, Vladimir Makarov, Cristina Valero +29 more

MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-003917

N/A

0DataRank · unranked

70 citations

Jonathan Zorea, Sankar Jagadeeshan, Avital Beeri Shnerb, Sooraj Mathukkada, Jebrane Bouaoud +27 more

Pre-treatment serum albumin and mutational burden as biomarkers of response to immune checkpoint blockade

npj Precision Oncology(2022)10.1038/s41698-022-00267-7

N/A

0DataRank · unranked

48 citations

Diego Chowell, Cristina Valero, Luc G.T. Morris, Timothy A. Chan, Seong‐Keun Yoo

Clonal hematopoiesis and differential outcomes after immune checkpoint blockade

Cancer Cell(2022)10.1016/j.ccell.2022.08.024

N/A

0DataRank · unranked

30 citations

Hannah J. Sfreddo, Karena Zhao, Catherine Y. Han, Luc G.T. Morris, David Hsiehchen

Immune Determinants of the Association between Tumor Mutational Burden and Immunotherapy Response across Cancer Types

Cancer Research(2022)10.1158/0008-5472.can-21-2542

N/A

0DataRank · unranked

43 citations

Sanju Sinha, Cristina Valero, Alejandro A. Schäffer, Kenneth Aldape, Kevin Litchfield +4 more

Young non-smokers with oral cancer: What are we missing and why?

Oral Oncology(2022)10.1016/j.oraloncology.2022.105803

N/A

0DataRank · unranked

30 citations

Avery Yuan, Daniella K. Zanoni, Emily Lei, Snjezana Doğan, Jatin P. Shah +6 more

Relative Survival With Early-Stage Breast Cancer in Screened and Unscreened Populations

Mayo Clinic Proceedings(2022)10.1016/j.mayocp.2022.08.006

N/A

0DataRank · unranked

13 citations

Luc G.T. Morris, Jennifer L. Marti, Andrea Marcadis

503 Cytotoxic revival is implicated in response to neoadjuvant PD-1 blockade for head and neck squamous cell carcinoma

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0503

N/A

0DataRank · unranked

2 citations

Giacomo Oliveira, Ann Marie Egloff, Zexiang Zeng, Rebecca D. Chernock, Liye Zhou +33 more

Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer

Science Immunology(2023)10.1126/sciimmunol.adf4968

N/A

0DataRank · unranked

118 citations

Ann Marie Egloff, Alexander B. Afeyan, Jacquelyn O. Wolff, Zexiang Zeng, Rebecca D. Chernock +34 more

Activation of the EGFR / PI3K / AKT pathway limits the efficacy of trametinib treatment in head and neck cancer

Molecular Oncology(2023)10.1002/1878-0261.13500

N/A

0DataRank · unranked

34 citations

Avital Beeri Shnerb, Divyasree Marripati, Sankar Jagadeeshan, Raghda Abu Shareb, Cristina Conde‐López +13 more

Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma

Journal of Clinical Investigation(2023)10.1172/jci169823

N/A

0DataRank · unranked

31 citations

Mahdi Golkaram, Joris L. Vos, Bin Xu, Conall Fitzgerald, Mark Lee +17 more

Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2882

N/A

0DataRank · unranked

34 citations

Mahesh Saqcena, Fengshen Kuo, Ravinder K. Grewal, Nicholas D. Socci, Jeffrey A. Knauf +8 more

Loss of Human Leukocyte Antigen and Immune Escape in Head and Neck Cancer

The Laryngoscope(2023)10.1002/lary.30761

N/A

0DataRank · unranked

9 citations

Luc G.T. Morris

Stem cell-like T cell depletion in the recurrent head and neck cancer immune microenvironment

OncoImmunology(2023)10.1080/2162402x.2023.2230666

N/A

0DataRank · unranked

2 citations

Nancy Y. Lee, Reith Sarkar, Nora Katabi, Yanyun Li, Luc G.T. Morris +6 more

CD66b as a prognostic and predictive biomarker in patients with non-small cell lung cancer treated with checkpoint blockade immunotherapy

Translational Cancer Research(2023)10.21037/tcr-22-2880

N/A

0DataRank · unranked

6 citations

Kevin Ma, Luc G.T. Morris, Swati Jain

Patterns of immune equilibrium and escape in indolent and progressing tumors

Cancer Cell(2023)10.1016/j.ccell.2023.06.003

N/A

0DataRank · unranked

5 citations

Maximilian Linxweiler, Fengshen Kuo, Jennifer L. Marti, Benjamin R. Roman, Behfar Ehdaie +3 more

Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0120

N/A

0DataRank · unranked

4 citations

Fengshen Kuo, Vladimir Makarov, Yiyu Dong, Ronald Ghossein, Bin Xu +3 more

Validation of a Machine Learning Model to Predict Immunotherapy Response in Head and Neck Squamous Cell Carcinoma

Cancers(2023)10.3390/cancers16010175

N/A

0DataRank · unranked

3 citations

Cristina Valero, Seong‐Keun Yoo, Joris L. Vos, Diego Chowell, Luc G.T. Morris +1 more

Data from High Response Rate and Durability Driven by HLA Genetic Diversity in Patients with Kidney Cancer Treated with Lenvatinib and Pembrolizumab

(2023)10.1158/1541-7786.c.6545243

N/A

0DataRank · unranked

2 citations

Renzo G. DiNatale, Diego Chowell, Chirag Krishna, Vladimir Makarov, Cristina Valero +21 more

Data from The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype

(2023)10.1158/1078-0432.c.6529017.v1

N/A

0DataRank · unranked

0 citations

Fengshen Kuo, Nora Katabi, Mark Lee, Zaineb Nadeem, Martin G. Dalin +11 more

Data from Genomic and Transcriptomic Correlates of Thyroid Carcinoma Evolution after BRAF Inhibitor Therapy

(2023)10.1158/1541-7786.c.6545222.v1

N/A

0DataRank · unranked

0 citations

Brian R. Untch, Bin Xu, Ronald Ghossein, Catherine Y. Han, Fengshen Kuo +12 more

Robust prediction of patient outcomes with immune checkpoint blockade therapy for cancer using common clinical, pathologic, and genomic features

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.07.04.547697

N/A

0DataRank · unranked

0 citations

Yingying Cao, Hannah J. Sfreddo, Saugato Rahman Dhruba, Se‐Hoon Lee, Cristina Valero +5 more

Robust prediction of patient outcomes with immune checkpoint blockade therapy for cancer using common clinical, pathologic, and genomic features

Research Square(2023)10.21203/rs.3.rs-3087126/v1

N/A

0DataRank · unranked

0 citations

Tiangen Chang, Yingying Cao, Hannah Sfreddo, Saugato Rahman Dhruba, Se‐Hoon Lee +5 more

Tumor and blood B-cell abundance outperforms established immune checkpoint blockade response prediction signatures in head and neck cancer

Annals of Oncology(2024)10.1016/j.annonc.2024.11.008

N/A

0DataRank · unranked

22 citations

Aris Spathis, Alejandro A. Schäffer, N. Gavrielatou, Fengshen Kuo, Dongya Jia +19 more

RAS -Mutated Cytologically Indeterminate Thyroid Nodules: Prevalence of Malignancy and Behavior Under Active Surveillance

Thyroid(2024)10.1089/thy.2023.0544

N/A

0DataRank · unranked

12 citations

Elizabeth S. Koh, Karena Zhao, Christina E. Swartzwelder, Brian R. Untch, Jennifer L. Marti +13 more

Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation

Oncotarget(2024)10.18632/oncotarget.28544

N/A

0DataRank · unranked

9 citations

Luc G.T. Morris, Mark Lee

Long-Term Results of External Beam Radiation Therapy (RT) with or without Concurrent Chemotherapy in Loco-Regionally Advanced or Recurrent Differentiated Thyroid Cancer (DTC)

International Journal of Radiation Oncology*Biology*Physics(2024)10.1016/j.ijrobp.2024.07.1633

N/A

0DataRank · unranked

1 citations

E. Sherman, Irini Youssef, Jung Julie Kang, Kaveh Zakeri, Yao Yu +15 more

Active Surveillance for Pleomorphic Adenomas of the Parotid—Tumor Growth Rate, Potential Malignancy, and Surgical Sequalae

Journal of Surgical Oncology(2024)10.1002/jso.27977

N/A

0DataRank · unranked

0 citations

Tejas Subramanian, Alana Eagan, Daniel W. Scholfield, Joseph Lopez, Nora Katabi +7 more

Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data

Nature Medicine(2025)10.1038/s41591-024-03398-5

N/A

0DataRank · unranked

111 citations

Conall Fitzgerald, Byuri Angela Cho, Bailey G. Fitzgerald, Catherine Y. Han, Elizabeth S. Koh +32 more

Neutrophil to lymphocyte ratio varies in magnitude and biomarker utility based on patient demographics

Journal of Clinical Investigation(2025)10.1172/jci198948

N/A

0DataRank · unranked

2 citations

Travis Kerr, Ananya Kodiboyena, Cristina Valero, Joris L. Vos, Vladimir Makarov +7 more

Sympathetic axonogenesis promotes adenoid cystic carcinoma progression

The Journal of Experimental Medicine(2025)10.1084/jem.20242250

N/A

0DataRank · unranked

6 citations

Boris Reva, Nora Katabi, Avishai Wizel, Hong-Bo Xu, Alan L. Ho +7 more

Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy

Nature Cancer(2020)10.1038/s43018-020-00139-8

N/A

0DataRank · unranked

214 citations

Chirag Krishna, Xiaoxiao Ma, Xin Pei, Ken-Wing Lee, Vladimir Makarov +23 more

The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3758

N/A

0DataRank · unranked

126 citations

Fengshen Kuo, Nora Katabi, Mark Lee, Zaineb Nadeem, Martin G. Dalin +11 more

Immune Cytolytic Activity for Comprehensive Understanding of Immune Landscape in Hepatocellular Carcinoma

Cancers(2020)10.3390/cancers12051221

N/A

0DataRank · unranked

76 citations

Tsutomu Kawaguchi, Li Yan, Xuan Peng, Qianya Qi, Luc G.T. Morris +5 more

DNA Repair Gene Mutations as Predictors of Immune Checkpoint Inhibitor Response beyond Tumor Mutation Burden

Cell Reports Medicine(2020)10.1016/j.xcrm.2020.100034

N/A

0DataRank · unranked

75 citations

Antony Hsieh, Robert Samstein, Tianshi Lu, Muhammad Shaalan Beg, David E. Gerber +4 more

Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa095

N/A

0DataRank · unranked

65 citations

Dana L. Casey, Yue Christine Lu, Margaret Hannum, Zhigang Zhang, Xinmao Song +26 more

Racial Disparities in Cancer Presentation and Outcomes: The Contribution of Overdiagnosis

JNCI Cancer Spectrum(2020)10.1093/jncics/pkaa001

N/A

0DataRank · unranked

14 citations

Louise Davies, Jennifer L. Marti, Luc G.T. Morris, Andrea Marcadis

Assessing the Number of Candidates There Are for Active Surveillance of Low-risk Papillary Thyroid Cancers in the US

JAMA Otolaryngology–Head & Neck Surgery(2020)10.1001/jamaoto.2020.0523

N/A

0DataRank · unranked

11 citations

Piyush B. Gupta, R. Michael Tuttle, Luc G.T. Morris, Shivangi Lohia, Benjamin R. Roman

Life Expectancy and Treatment Patterns in Elderly Patients With Low-Risk Papillary Thyroid Cancer: A Population-Based Analysis

Endocrine Practice(2020)10.1016/j.eprac.2020.12.004

N/A

0DataRank · unranked

8 citations

Piyush B. Gupta, Michael Curry, Luc G.T. Morris, Benjamin R. Roman, Shivangi Lohia

Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancer

Immunity(2021)10.1016/j.immuni.2021.02.020

N/A

0DataRank · unranked

123 citations

Katja Srpan, Elisa E. Sanchez, Jing Hu, Ján Remšík, Yevgeniy Romin +10 more

Transoral robotic surgery adoption and safety in treatment of oropharyngeal cancers

Cancer(2021)10.1002/cncr.33995

N/A

0DataRank · unranked

41 citations

Michael J. Persky, Binhuan Wang, Umamaheswar Duvvuri, Neil D. Gross, Alec Vaezi +3 more

Impact of tumor mutational burden on checkpoint inhibitor drug eligibility and outcomes across racial groups

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003683

N/A

0DataRank · unranked

23 citations

Magdalena Espinoza, Cristina Valero, Chul Ahn, Luc G.T. Morris, David Hsiehchen